Life Therapeutics

Company Overview

Snapshot

Founded in October 2023, Life Therapeutics operates with 1–10 employees. The company has secured funding across one round from one investor, with Peregrine Ventures participating. In March 2024, Life Therapeutics received seed funding, indicating early investor confidence in its precision immunotherapy approach.

Business overview

Life Therapeutics is a Health Tech & Life Sciences company focused on developing precision immunotherapies. The company's core technology targets circulating tumor cells, aiming to provide advanced treatment options in the oncology and pharmaceuticals sectors. Operating within the Drugs Discovery & Development category, Life Therapeutics serves the medical biotechnology market with a B2B business model, currently in the R&D product stage.

Company Intelligence Q&A

When was Life Therapeutics founded?

Life Therapeutics was founded in October 2023.

What is Life Therapeutics' primary focus?

Life Therapeutics specializes in precision immunotherapies targeting circulating tumor cells, operating within the Health Tech & Life Sciences sector.

Which investor participated in Life Therapeutics' funding round?

In March 2024, Peregrine Ventures participated in a funding round for Life Therapeutics.

What is the current employee count for Life Therapeutics?

Life Therapeutics currently has 1–10 employees.

What is Life Therapeutics' business model and product stage?

Life Therapeutics operates on a B2B business model and is currently in the R&D product stage, focusing on drug discovery and development.